Medical Advocates
CMX157
 
Main Page

New and Noteworthy
Journal Data
 





 
ARV Investigational  Drugs Main New/Noteworthy Home Page      
Last Update:  August 21, 2010
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
 
July 2010
 
Journal Abstracts , Papers, and Commentaries
 
 
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection
caused by wild-type and nucleoside/nucleotide-resistant HIV.
 Lanier ER, Ptak RG, Lampert BM,  et al
Antimicrob Agents Chemother. 2010 Jul;54(7):2901-9.
 Abstract
 

ARV Investigational  Drugs Main New/Noteworthy Home Page      

CMX-157